You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 28, 2015

Animal Feed Control: An Update on Thailand’s Legislation

Subscribe to Updates
Informed Counsel

Thailand’s roadmap of food safety, which was approved in 2004, aims to promote the Kingdom as the “kitchen of the world.” Animal feed, i.e., food given to farm animals, plays a major role in the food safety regime—it is part of the stages of food production, dubbed “farm-to-table,” and is an integral component in the overarching food chain. Animal feed must be as safe as meat for human consumption, and therefore registration, inspection, and control of animal feed are vigorously regulated by the regulatory authorities.

The Department of Livestock Development (DLD), Ministry of Agriculture and Cooperatives (MoAC), is the main authority responsible for putting in place a system for the management and control of animal feed. With the tremendous growth in the animal feed business, a new government unit, the Division of Animal Feed and Veterinary Products Control, was established within the DLD on September 26, 2013. This unit is responsible for the control of animal feed and hazardous substances for use in livestock production, as stipulated in the Animal Feed Quality Control Act and the Hazardous Substance Act, respectively.

Due to the rapid evolution of technology, as well as innovation in animal feed and husbandry, animal feed businesses in Thailand have expanded significantly. Much like the changes in food safety and technology, the law controlling animal feed in Thailand has evolved over time. Animal feed was previously regulated under the Animal Feed Quality Control Act B.E. 2506 (1963 Act). The 1963 Act was replaced with the Animal Feed Quality Control Act B.E. 2525 (1983 Act). Then, in 1999, there was an amendment of the Act. And very recently, the Animal Feed Quality Control Act B.E. 2558 (2015 Act) was announced in the Royal Gazette, which came into force on March 5, 2015.

Under the 2015 Act, “specific control animal feed”  must be registered prior to domestically manufacturing or importing animal feed into the Kingdom of Thailand. This term was not defined under the previous Act. The term is very broad in meaning, as it covers feed that has an impact on socioeconomic problems, feed that will probably harm animals, or feed that will have an effect on consumers of meat.

In the future, the MoAC minister will announce the type, quality standard, conditions, and requirements for registration of such animal feed. The types of animal feed that currently require registration include premix, milk products for animals, feed supplements, feed mixed with veterinary drugs, and more.

Veterinary drugs, on the other hand, are regulated by the Thai Food and Drug Administration. Animal drugs must be registered, following the Drug Act B.E. 2510 (1967), as amended. While a drug product license can be transferred from one juristic person to another, an animal feed registration license cannot be transferred. In addition, if the registered animal feed has not been manufactured or imported for two years, the MoAC minister has the power to revoke the registration license of such animal feed. These are the important precautions that animal feed companies should keep in mind.

The 2015 Act allows officers to inspect premises for the importation or manufacturing of animal feed during the daytime, in cases where unlawful action is suspected. Officers may sample the animal feed in a sufficient quantity for further analysis and testing. Under the 2015 Act, officers are also empowered to issue a requisition letter to call persons to provide testimony or submit documents for further consideration. In addition, the 2015 Act also includes additional provisions regarding the issuance of quality assurance certificates by the DLD and the termination of business.

The 2015 Act is a good sign that the responsible authorities are taking measures to preserve the wellbeing of animals and ensure food safety. Those in the animal feed business should closely monitor animal-feed-related ministerial regulations, which will likely be issued in the near future. It is expected that the 2015 Act will improve the registration and surveillance of animal feed, and ultimately, will ensure greater safety for meat consumers.

Download Full Article
Related Professionals

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

January 5, 2026
On December 31, 2025, Vietnam’s Ministry of Health (MOH) issued Circular No. 57/2025/TT-BYT providing guidance on the classification of medical devices according to technical standards and quality requirements (Circular 57), applicable to procurement activities for medical devices in Vietnam. According to the MOH, the purpose of the classification is to establish a principle-based legal framework and regulations that enable purchasers to easily identify groups of medical devices aligned with their professional requirements and financial capacity. Some of the key stipulations of Circular 57 are outlined below. Basis for Determining Technical Standards and Quality Under Circular 57, the technical standards of medical devices are determined in accordance with Vietnamese laws on standards and technical regulations, through the following means: Certification of conformity with standards in accordance with Vietnamese laws on standards and technical regulations; Results of conformity assessment conducted by an internationally recognized conformity assessment organization or a legally established domestic or foreign conformity assessment organization operating in Vietnam; and Documentation evidencing compliance provided by the medical device owner. The quality of medical devices is determined based on whether the device has been approved for circulation by the relevant marketing authority of one or more jurisdictions. Classification of Medical Devices Circular 57 classifies medical devices into six groups (from Group 1 to Group 6) based on technical standards and quality. Medical devices subject to classification must simultaneously meet technical standards and quality requirements in accordance with professional specifications and user needs, and must be lawfully marketed in Vietnam. Medical devices manufactured in Vietnam may participate in all corresponding groups, provided they meet the technical standards required by the user and are lawfully marketed in Vietnam. Outlook Circular No. 57 will take effect on February 15, 2026, while the classification requirements will become effective on January 1, 2027. Holders of medical
Read More
December 30, 2025
The Intellectual Property Office of Vietnam (IP Office), with support from the Japan International Cooperation Agency (JICA), is drafting additional annexes to its Guidelines for Patent Examination, focusing on the examination of patent applications in the pharmaceutical and biotechnology sectors. The new annexes are expected to be officially issued in early 2026 as Annexes III and IV, following the successful issuance in 2023 of Annexes I and II addressing computer program-related inventions. The IP Office recently organized a seminar to gather feedback on the draft annexes from intellectual property representatives, academic institutions, research institutes, and other interested parties, emphasizing its intention to receive further constructive opinions to refine the guidelines for pharmaceuticals and biotechnology. Why These Guidelines Matter Patent examination in Vietnam has traditionally relied on the Guidelines for Patent Examination issued under Decision No. 487/QD-SHTT (2010), recently supplemented by Annexes I and II. While these documents provide a solid foundation, they do not fully address practical challenges in examining pharmaceutical and biotech inventions, particularly issues related to clarity, sufficiency of disclosure, enablement, features of function and utility, combination therapies, and inventions involving artificial intelligence (AI) applications in these fields. Annexes III and IV aim to close these gaps by introducing structured principles and illustrative examples. Guidance on Patent Specification Requirements Annex III provides detailed guidance on the requirements for patent specifications in pharmaceuticals and biotechnology, covering two main parts: Part A addresses sufficiency of disclosure, clarity of specifications, and consistency between claims and descriptions. Part B covers inventions related to Markush-type compounds, claims containing exclusion statements (disclaimers), and additional experimental data submitted during examination. The Guidelines outline specific disclosure requirements for subject matters such as compounds, formulations, pharmaceutical compositions, genes, polypeptides, proteins, vectors, transgenic organisms, modified organisms, and hybrid cells. Annex III emphasizes that disclaimers are not accepted
Read More
November 25, 2025
Food safety incidents can emerge without warning, requiring businesses to act swiftly to protect consumers and comply with regulatory obligations. Across Southeast Asia, Thailand, Vietnam, and Indonesia have each developed comprehensive food recall frameworks designed to ensure rapid removal of unsafe products from the market while holding businesses accountable for compliance failures. While these three jurisdictions share common objectives—protecting public health and ensuring food safety—each has crafted distinct regulatory approaches reflecting their unique administrative structures, enforcement priorities, and legal traditions. Understanding these differences is essential for food businesses operating in the region, as recall procedures, timelines, reporting requirements, and penalties vary significantly across borders. This guide, available through the button below, examines the food recall regulations in Indonesia, Thailand, and Vietnam, providing practical guidance on legal requirements, procedural steps, and compliance obligations in each market.
Read More